Latest Conference Articles

Durga Borkar, MD, MMCi, explores real-world treatment patterns and safety of avacincaptad pegol for geographic atrophy, revealing critical insights for patient care.

Dr Borkar, a vitreoretinal surgeon at Duke University, spoke to the Eye Care Network about her American Academy of Ophthalmology (AAO) presentation

AAO attendees can preview the new technician training platform on Sunday, October 19.

Jean-Francois Korobelnik, MD, shares highlights from the PULSAR extension study showcasing aflibercept 8 mg and its ability to promote fluid resolution

Data suggests the candidate can reduce the number of injections and treatment burden for patients

This year, 18 presenters will deliver named lectures during the American Academy of Ophthalmology meeting.

An easy reference guide for this year's award lectures and subspecialty day keynotes.

The video-driven platform will improve workflow, education and engagement, said Inder Paul Singh, MD.

The video-driven platform will improve workflow, education and engagement, said Inder Paul Singh, MD

The EURETINA meeting featured new treatments in gene therapy and innovative implants to enhance patient quality of life.

Dr. Kristina Pfau discusses her research on pseudoxanthoma elasticum and the initiatives of EURETINA's Young Ophthalmologist and Retina Specialists Committee.

KOLs in the retina world reflect on advice they would share with fellows beginning their journey into retina, including the vast opportunities in healthcare and the importance of curiosity and collaboration for revolutionary advancements in retina medicine.

Singh highlights how understanding the “why” behind diagnostics and procedures boosts technician confidence, fosters pride, and strengthens their role in patient care.

Dr Chhablani said "having multiple approaches to the same problem" is key for reaching the maximum number of patients with age-related macular degeneration

Ultra-high-resolution OCT advances retinal imaging, enabling detailed visualization of disease progression and potential therapeutic effects in eye conditions.

The Phase 1/2 ArMaDa trial is evaluating OCU410 (Ocugen), a gene therapy candidate for patients with dry age-related macular degeneration.

The video-driven platform equips ophthalmic practices with tools to standardize education, improve workflow, and foster technician engagement.

The agenda includes subspecialty days, evening events and partner programmes from practice management organisations

Join the American Academy of Ophthalmology's annual meeting for cutting-edge insights, networking, and engaging events from October 17-20 in Orlando.

Learn how the YOURS Committee empowers young retina specialists through engaging educational initiatives, networking opportunities, and exam preparation resources.

Discover key insights from leading ophthalmology experts at the AAO meeting, featuring presentations, posters, and innovative discussions from October 17-20.

Holz discusses advancements in retinal disease treatments at the EURETINA meeting, featuring gene therapy and innovative implants to enhance patient care.